Elsevier

The Lancet

Volume 338, Issue 8761, 27 July 1991, Pages 207-211
The Lancet

ORIGINAL ARTICLES
Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene

https://doi.org/10.1016/0140-6736(91)90348-SGet rights and content

Abstract

The diagnosis of haemophilia A and the identification of carriers has greatly improved with knowledge of the structure of the gene for factor VIII. This has permitted the defect to be tracked in families by the study of restriction fragment length polymorphisms (RFLPs), irrespective of the nature of the molecular defect. However, this approach is time-consuming and the information yielded falls away as more polymorphisms are added. Within the factor VIII gene lies another source of polymorphism, a dinucleotide repeat sequence of varying length known as (CA)n. Conventional mapping localised this (CA)n repeat to intron 13. The polymerase chain reaction, used to examine (CA)n variability in genomic DNA from 25 males and 67 females, revealed eight allelic bands between n=16 and n=24. 91% of females were heterozygous for this repeat, and family studies showed X-linked mendelian inheritance with allelic frequencies ranging from 1% to 45%. The intron 13 (CA)n repeat is tightly linked with established RFLPs and tracks with haemophilia A in family studies. The analysis requires DNA from other family members, and relatives of sporadic cases of haemophilia A are only amenable to exclusion. Nonetheless, this intron 13 (CA)n repeat provides the most highly informative marker so far available for factor VIII gene tracking studies in haemophilia A kindreds and a result can be available within a day.

References (28)

  • P. Ahrens et al.

    A new HindIII restriction fragment length polymorphism in the haemophilia A locus

    Hum Genet

    (1987)
  • Vl Surin et al.

    Simple and convenient detection of a HindIII polymorphic site in intron 19 of factor VIII using PCR

    Nucl Acids Res

    (1990)
  • Jb Graham et al.

    The utility of a HindIII polymorphism of factor VIII examined by rapid DNA analysis

    Br J Haematol

    (1990)
  • Cited by (136)

    • Overrepresentation of missense mutations in mild hemophilia A patients from Belgium: Founder effect or independent occurrence?

      2015, Thrombosis Research
      Citation Excerpt :

      This was in order to facilitate the interpretation of results obtained by haplotype analysis. Flanking markers from 1.4 Mb centromeric to 0.6 Mb telomeric of the F8 locus were genotyped, including the four previously reported [6,8,12,16] extragenic and intronic microsatellites (3’ DXS15–DXSint22–DXSint13–DXS1108-5’) and ten SNPs, as displayed in Table 1. The PCR was conducted in a 25 μL containing 1x PCR Faststart buffer, 1U of Faststart Taq polymerase (Hoffmann-La Roche, Basel, Switzerland), 0.2 mM of each dNTP, and 10pmol of each primer.

    • Profile of genetic disorders prevalent in northeast region of Cairo, Egypt

      2012, Egyptian Journal of Medical Human Genetics
      Citation Excerpt :

      In 2000, Khalifa et al. [65] also reported the possibility to offer diagnosis in 68.4% of the studied families with the combined use of both intron 13 and intron 22 repeats. Intron 13 and 22 of factor VIII gene are multi allelic- dinucleotide tandem repeats used for indirect gene tracking [66,67]. Chromosomal disorders represented a significant class of genetic disorders in Egypt and constituted 11.77% and 0.51% in genetics and general pediatrics clinics, respectively (Table 4).

    • Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience

      2020, American Journal of Medical Genetics, Part C: Seminars in Medical Genetics
    • Procoagulant control strategies for the human blood clotting process

      2015, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
    View all citing articles on Scopus
    View full text